Kawasaki disease other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Kawasaki disease}} | {{Kawasaki disease}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{SH}} | ||
==Overview== | ==Overview== | ||
Urinalysis, [[lumbar puncture]], [[biomarkers]] evaluation, and [[angiography]] may be helpful in the diagnosis of Kawasaki disease. | |||
== Other Diagnostic Studies == | == Other Diagnostic Studies == | ||
Other diagnostic tests include: | Other diagnostic tests include:<ref name="pmid26761773">{{cite journal |vauthors=Watanabe K, Suzuki H, Jiang M, Haniu H, Numano F, Hoshina S, Saitoh A, Uchiyama M, Bujo H |title=Soluble LR11 is a novel biomarker for vascular lesions late after Kawasaki disease |journal=Atherosclerosis |volume=246 |issue= |pages=94–7 |date=March 2016 |pmid=26761773 |doi=10.1016/j.atherosclerosis.2015.12.035 |url=}}</ref> | ||
* [[Urinalysis]] | * [[Urinalysis]] | ||
** May demonstrate white blood cells and protein in the urine (sterile [[pyuria]] and [[proteinuria]], respectively) without evidence of bacterial growth | ** May demonstrate white blood cells and protein in the urine (sterile [[pyuria]] and [[proteinuria]], respectively) without any evidence of bacterial growth. | ||
* [[Lumbar puncture]] | * [[Lumbar puncture]] | ||
** May demonstrate evidence of [[aseptic meningitis]] | ** May demonstrate evidence of [[aseptic meningitis]]. | ||
* [[Angiography]] | * [[Angiography]] | ||
** May be used to detect coronary artery aneurysms and remains the gold standard for their detection, but is rarely used today unless coronary artery aneurysms have already been detected by echocardiography. | ** May be used to detect coronary artery aneurysms and remains the gold standard for their detection, but is rarely used today unless coronary artery aneurysms have already been detected by echocardiography. | ||
*[[Biomarkers]] | *[[Biomarkers]] | ||
**Soluble LR11 may provide evidence vascular lesions in Kawasaki disease. | **Soluble LR11 may provide evidence of vascular lesions in Kawasaki disease. | ||
==References== | ==References== | ||
Latest revision as of 17:15, 18 February 2020
|
Kawasaki disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
American Roentgen Ray Society Images of Kawasaki disease other diagnostic studies |
|
Risk calculators and risk factors for Kawasaki disease other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]
Overview
Urinalysis, lumbar puncture, biomarkers evaluation, and angiography may be helpful in the diagnosis of Kawasaki disease.
Other Diagnostic Studies
Other diagnostic tests include:[1]
- Urinalysis
- May demonstrate white blood cells and protein in the urine (sterile pyuria and proteinuria, respectively) without any evidence of bacterial growth.
- Lumbar puncture
- May demonstrate evidence of aseptic meningitis.
- Angiography
- May be used to detect coronary artery aneurysms and remains the gold standard for their detection, but is rarely used today unless coronary artery aneurysms have already been detected by echocardiography.
- Biomarkers
- Soluble LR11 may provide evidence of vascular lesions in Kawasaki disease.
References
- ↑ Watanabe K, Suzuki H, Jiang M, Haniu H, Numano F, Hoshina S, Saitoh A, Uchiyama M, Bujo H (March 2016). "Soluble LR11 is a novel biomarker for vascular lesions late after Kawasaki disease". Atherosclerosis. 246: 94–7. doi:10.1016/j.atherosclerosis.2015.12.035. PMID 26761773.